当前位置:
X-MOL 学术
›
Nat. Rev. Clin. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Targeted therapy: ARIEL3 — broad benefit of PARP inhibitors in ovarian cancer
Nature Reviews Clinical Oncology ( IF 81.1 ) Pub Date : , DOI: 10.1038/nrclinonc.2017.161 David Killock
Nature Reviews Clinical Oncology ( IF 81.1 ) Pub Date : , DOI: 10.1038/nrclinonc.2017.161 David Killock
Targeted therapy: ARIEL3 — broad benefit of PARP inhibitors in ovarian cancer
中文翻译:
靶向治疗:ARIEL3 — PARP抑制剂在卵巢癌中的广泛益处
靶向治疗:ARIEL3 — PARP抑制剂在卵巢癌中的广泛益处
更新日期:2017-10-11
Nature Reviews Clinical Oncology, Published online: 10 October 2017; doi:10.1038/nrclinonc.2017.161
中文翻译:
靶向治疗:ARIEL3 — PARP抑制剂在卵巢癌中的广泛益处
靶向治疗:ARIEL3 — PARP抑制剂在卵巢癌中的广泛益处
Nature Reviews Clinical Oncology,在线发布:2017年10月10日;doi:10.1038 / nrclinonc.2017.161